2113 related articles for article (PubMed ID: 11836629)
21. Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors in the brain.
Shioda S
Kaibogaku Zasshi; 2000 Dec; 75(6):487-507. PubMed ID: 11197592
[TBL] [Abstract][Full Text] [Related]
22. Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes.
Grimaldi M; Cavallaro S
Eur J Neurosci; 1999 Aug; 11(8):2767-72. PubMed ID: 10457173
[TBL] [Abstract][Full Text] [Related]
23. [Pituitary adenylate cyclase-activating polypeptide].
Gonzalez BJ; Basille M; Vaudry D; Fournier A; Vaudry H
Ann Endocrinol (Paris); 1998 Dec; 59(5):364-405. PubMed ID: 9949891
[TBL] [Abstract][Full Text] [Related]
24. Progesterone receptor activation mediates LH-induced type-I pituitary adenylate cyclase activating polypeptide receptor (PAC(1)) gene expression in rat granulosa cells.
Ko C; Park-Sarge OK
Biochem Biophys Res Commun; 2000 Oct; 277(1):270-9. PubMed ID: 11027674
[TBL] [Abstract][Full Text] [Related]
25. PACAP, VIP, and PHI: effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures.
Dejda A; Jozwiak-Bebenista M; Nowak JZ
Ann N Y Acad Sci; 2006 Jul; 1070():220-5. PubMed ID: 16888170
[TBL] [Abstract][Full Text] [Related]
26. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
Apostolakis EM; Riherd DN; O'Malley BW
Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
[TBL] [Abstract][Full Text] [Related]
27. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D
Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905
[TBL] [Abstract][Full Text] [Related]
28. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
[TBL] [Abstract][Full Text] [Related]
29. Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity.
Margiotta JF; Pardi D
Mol Pharmacol; 1995 Jul; 48(1):63-71. PubMed ID: 7623776
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock.
Martínez C; Juarranz Y; Abad C; Arranz A; Miguel BG; Rosignoli F; Leceta J; Gomariz RP
J Leukoc Biol; 2005 May; 77(5):729-38. PubMed ID: 15661828
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of PACAP receptors in postnatal rat brain.
Shneider Y; Shtrauss Y; Yadid G; Pinhasov A
Neuropeptides; 2010 Dec; 44(6):509-14. PubMed ID: 20971507
[TBL] [Abstract][Full Text] [Related]
32. Ageing and the diurnal expression of mRNAs for vasoactive intestinal peptide and for the VPAC2 and PAC1 receptors in the suprachiasmatic nucleus of male rats.
Kalló I; Kalamatianos T; Piggins HD; Coen CW
J Neuroendocrinol; 2004 Sep; 16(9):758-66. PubMed ID: 15344914
[TBL] [Abstract][Full Text] [Related]
33. Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance.
Alexandre D; Vaudry H; Grumolato L; Turquier V; Fournier A; Jégou S; Anouar Y
Endocrinology; 2002 Jul; 143(7):2680-92. PubMed ID: 12072402
[TBL] [Abstract][Full Text] [Related]
34. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.
Cunha-Reis D; Ribeiro JA; Sebastião AM
Brain Res; 2005 Jul; 1049(1):52-60. PubMed ID: 15935995
[TBL] [Abstract][Full Text] [Related]
35. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
[TBL] [Abstract][Full Text] [Related]
36. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery.
Vaudry D; Falluel-Morel A; Bourgault S; Basille M; Burel D; Wurtz O; Fournier A; Chow BK; Hashimoto H; Galas L; Vaudry H
Pharmacol Rev; 2009 Sep; 61(3):283-357. PubMed ID: 19805477
[TBL] [Abstract][Full Text] [Related]
37. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
[TBL] [Abstract][Full Text] [Related]
38. Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development.
Basille M; Cartier D; Vaudry D; Lihrmann I; Fournier A; Freger P; Gallo-Payet N; Vaudry H; Gonzalez B
J Comp Neurol; 2006 Jun; 496(4):468-78. PubMed ID: 16572459
[TBL] [Abstract][Full Text] [Related]
39. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of mRNAs for PACAP and its receptors during neural differentiation of embryonic stem cells.
Hirose M; Hashimoto H; Shintani N; Nakanishi M; Arakawa N; Iga J; Niwa H; Miyazaki J; Baba A
Regul Pept; 2005 Mar; 126(1-2):109-13. PubMed ID: 15620423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
